FDA Approved: IBANDRONATE SODIUM — Supplemental Application (Apotex Corp.)

View source ↗

Summary

The FDA approved a supplemental application for ibandronate sodium from Apotex Corp. under ANDA204222. This represents an update to the previously approved prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• IBANDRONATE SODIUM (ibandronate sodium)

Snippet

SUPPL AP for IBANDRONATE SODIUM (IBANDRONATE SODIUM)